Evidence map›Paper›PMID 36604774›Full record

ArticleMolecular pain

The holistic approach to the

Sedat Yasin, Şenay Görücü Yılmaz, Sırma Geyik, Sibel Oğuzkan Balcı

Open access · goldAbstract read
In one paragraph

Article in Molecular pain. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. The Role of MicroRNA in Migraine: A Systemic Literature Review.Cellular and molecular neurobiology · 2023
    Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sedat YasinDepartment of Neurology, 37512Gaziantep University, Gaziantep, Turkey.ORCID 0000-0001-8067-8388
Şenay Görücü YılmazDepartment of Nutrition and Dietetics, 37512Gaziantep University, Gaziantep, Turkey.ORCID 0000-0003-0523-7819
Sırma GeyikDepartment of Neurology, 37512Gaziantep University, Gaziantep, Turkey.
Sibel Oğuzkan BalcıDepartment of Medical Biology, 37512Gaziantep University, Gaziantep, Turkey.
Gaziantep University · TR

Funding

Wellcome Trust
6 · The paper itself

Abstract

Migraine is a neurological disease characterized by severe headache attacks. Combinations of different genetic variations such as copy number variation (CNV) in a gene and microRNA (miRNA) expression can provide a holistic approach to the disease as a pathophysiological, diagnostic, and therapeutic target. CNVs, the Cholinergic Receptor Nicotinic Alpha 7 Subunit (

Indexed as

alpha7 Nicotinic Acetylcholine ReceptorDNA Copy Number VariationsMicroRNAsMigraine DisordersCase-Control StudiesGenetic MarkersHumansalpha7 Nicotinic Acetylcholine ReceptorChrna7 protein, humanGenetic MarkersMicroRNAscholinergic receptor nicotinic alpha 7copy number variationhsa-miR-3158-5pmigraine disease

Identifiers

PMID36604774
PMCPMC9850133
OpenAlexW4313551480

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.